NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Thursday that its revenues in the first quarter were down 3 percent year over year, dropping to $393.4 million, compared to $405.6 million in Q1 2012.

The results fell short of the average Wall Street estimate of $417.0 million. Foreign currency effects were responsible for roughly half of that decline, the company said, with acquisitions and divestitures responsible for an additional net negative effect of a fraction of 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.